Pharmacological characterization of endomorphin-1 and endomorphin-2 in mouse brain

Journal of Pharmacology and Experimental Therapeutics

Volumn 286, Issue 2, 1998, Pages 1007-1013

  Goldberg, Ira E ^a   Rossi, Grace C ^a   Letchworth, Sharon R ^a   Mathis, John P ^a   Ryan Moro, Jennifer ^a   Leventhal, Liza ^a   Su, Wendy ^a   Emmel, David ^a   Bolan, Elizabeth A ^a   Pasternak, Gavril W ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA FUNALTREXAMINE; ENDOMORPHIN 1; ENDOMORPHIN 2; MU OPIATE RECEPTOR; NALOXONE;

ANALGESIA; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BRAIN; BRAIN HOMOGENATE; CHO CELL; CONTROLLED STUDY; GASTROINTESTINAL TRANSIT; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANALGESICS, OPIOID; ANIMALS; AUTORADIOGRAPHY; BRAIN; CHO CELLS; CRICETINAE; GASTROINTESTINAL TRANSIT; INJECTIONS, INTRAVENTRICULAR; IODINE RADIOISOTOPES; MALE; MEMBRANES; MICE; MICE, INBRED STRAINS; OLIGOPEPTIDES; PAIN MEASUREMENT; RECEPTORS, OPIOID, MU;

EID: 0032411116     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Atweh SF and Kuhar MJ (1977a) Autoradiographic localization of opiate receptors in rat brain. III. The telencephalon. Brain Res 134:393-405.
2. Atweh SF and Kuhar MJ (1977b) Autoradiographic localization of opiate receptors in rat brain. I. Spinal cord and lower medulla. Brain Res 124:53-67.
3. Atweh SF and Kuhar MJ (1977c) Autoradiographic localization of opiate receptors in rat brain. II. The brain stem. Brain Res 129:1-12.
4. Baron A, Shuster L, Elefterhiou BE and Bailey DW (1975) Opiate receptors in mice: genetic differences. Life Sci 17:633-640.
5. Brown GP, Yang K, King MA, Rossi GC, Leventhal L, Chang A and Pasternak GW (1997a) 3-Methoxynaltrexone, a selective heroin/morphine-6β-glucuronide antagonist. FEBS Lett 412:35-38.
6. 3H-morphine-6β-glucuronide binding in brain membranes and an MOR-I-transfected cell line. J Pharmacol Exp Ther 282: 1291-1297.
7. Chen Y, Mestek A, Liu J, Hurley JA and Yu L ()(1993) Molecular cloning and functional expression of a μ-opioid receptor from rat brain. Mol Pharmacol 44:8-12.
8. 50) of an enzymatic reaction. Biochem Pharmacol 22:3099-3108.
9. Chou T-C (1974) Relationships between inhibition constants and fractional inhibition in enzyme-catalyzed reactions with different numbers of reactants, different reaction mechanisms and different types and mechanisms of inhibition. Mol Pharmacol 10: 235-247.
10. 1 binding assay. Mol Pharmacol 34:308-317.
11. 3 subtype. J Pharmacol Exp Ther 251:461-468.
12. Evans CJ, Hammond DL and Frederickson RCA (1988) The opioid peptides, in The Opiate Receptors (Pasternak GW ed) pp 23-74. Humana Press, Clifton, NJ.
13. 1 opiate receptors in rat brain using a computerized autoradiographic subtraction technique. Proc Natl Acad Sci USA 82:6667-6671.
14. Hahn EF, Carroll-Buatti M and Pasternak GW (1982) Irreversible opiate agonists and antagonists: the 14-hydroxydihydromorphinone azines. J Neurosci 2:572-576.
15. Kuhar MJ, Pert CB and Snyder SH (1973) Regional distribution of opiate receptor binding in monkey and human brain. Nature 245:447-450.
16. Ling GSF, Simantov R, Clark JA and Pasternak GW (1986) Naloxonazine actions in vivo. Eur J Pharmacol 129:33-38.
17. Ling GSF and Pasternak GW (1983) Spinal and supraspinal opioid analgesia in the mouse: the role of subpopulations of opioid binding sites. Brain Res 271:152-156.
18. Lowry OH, Rosebrough NJ, Farr AL and Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275.
19. Luke MC, Hahn EF, Price M and Pasternak GW (1988) Irreversible opiate agonists and antagonists: V. Hydrazone and acylhydrazone derivatives of naltrexone. Life Sci 43:1249-1256.
20. Mathis JP, Ryan-Moro J, Chang A, Hom JSH, Scheinberg DA and Pasternak GW (1997) Biochemical evidence for orphanin FQ/nociceptin receptor heterogeneity in mouse brain. Biochem Biophys Res Commun 230:462-465.
21. 2 and delta opioid binding in the central nervous of C57BL/6BY and CXBK (opioid receptor-deficient) mice. Brain Res 360:108-116.
22. 2 opioid binding in the mouse central nervous system. Brain Res 360:117-129.
23. 3H]opiate agonist binding by divalent cations. Mol Pharmacol 11:478-484.
24. Pasternak GW, Wilson HA and Snyder SH (1975b) Differential effects of protein-modifying reagants on receptor binding of opiate agonists and antagonists. Mol Pharmacol 11:340-351.
25. Pasternak GW (1993) Pharmacological mechanisms of opioid analgesics. Clin Neuropharmacol 16:1-18.
26. Pasternak GW and Snyder SH (1975) Opiate receptor binding: Enzymatic treatments and discrimination between agonists and antagonists. Mol Pharmacol 11: 735-744.
27. Paul D, Standifer KM, Inturrisi CE and Pasternak GW (1989) Pharmacological characterization of morphine-6β-glucuronide, a very potent morphine metabolite. J Pharmacol Exp Ther 251:477-483.
28. Paul D and Pasternak GW (1988) Differential blockade by naloxonazine of two μ opiate actions: analgesia and inhibition of gastrointestinal transit. Eur J Pharmacol 149:403-404.
29. 2 opioid actions. Life Sci 48:2005-2011.
30. Pick CG, Nejat R and Pasternak GW (1993) Independent expression of two pharmacologically distinct supraspinal mu analgesic systems in genetically different mouse strains. J Pharmacol Exp Ther 2265:166-171.
31. Reisine T and Pasternak GW (1996) Opioid analgesics and antagonists, in Goodman and Gilman's: The Pharmacological Basis of Therapeutics (Hardman JG and Limbird LE eds) pp 521-556. McGraw-Hill, New York
32. Reith MEA, Sershen H, Vadasz C and Lajtha A (1981) Strain differences in opiate receptors in mouse brain. Eur J Pharmacol 74:377-380.
33. Rossi G, Leventhal L, Boland E and Pasternak GW (1997) Pharmacological characterization of orphanin FQ/nociceptin and its fragments. J Pharmacol Exp Ther 282:858-865.
34. Rossi GC, Pan Y-X, Brown GP and Pasternak GW (1995) Antisense mapping the MOR-1 opioid receptor: Evidence for alternative splicing and a novel morphine-6β-glucuronide receptor. FEBS Lett 369:192-196.
35. Rossi GC, Brown GP, Leventhal L, Yang K and Pasternak GW (1996) Novel receptor mechanisms for heroin and morphine-6β -glucuronide analgesia. Neurosci Lett 216:1-4.
36. Stone LS, Fairbanks CA, Laughlin TM, Nguyen HO, Bushy TM, Wessendorf MW and Wilcox GL (1997) Spinal analgesic actions of the new endogenous opioid peptides endomrophin-1 and -2. Neuroreport 8:3131-3135.
37. Tallarida RJ and Murray RB (1987) Manual of Pharmacological Calculations with Computer Programs, Springer-Verlag, New York.
38. Wang JB, Imai Y, Eppler CM, Gregor P, Spivak CE and Uhl GR (1993) μ opiate receptor: cDNA cloning and expression. Proc Natl Acad Sci USA 90:10230-10234.
39. Zadina JE, Hackler L, Ge LJ and Kastin AJ (1997) A potent and selective endogenous agonist for the μ-opiate receptor. Nature 386:499-502.